Lineage Cell Therapeutics, Inc.

LCTX

$1.10

-0.90%

N/A-$0.01

Healthcare

Biotechnology

AMEX

Active Trading

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and ...

Insider Transactions of LCTX

Acquisitions (A)

Since Mar 5, 2026

Disposals (D)

Since Mar 5, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 1, 2026	Bradsher Neal C	director, 10 percent owner:	OPTION TO PURCHASE COMMON SHARES	A	125,000	$1.30
Jul 1, 2026	Jayasuriya Anula	director	Stock Option (Right to Buy)	A	125,000	$1.30
Jul 1, 2026	Mulroy Michael H.	director	Stock Option (Right to Buy)	A	125,000	$1.30
Jul 1, 2026	ANDREWS DEBORAH J	director	Stock Option (Right to Buy)	A	125,000	$1.30
Jul 1, 2026	Russell Angus C.	director	Stock Option (Right to Buy)	A	125,000	$1.30

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

5,965,000

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Culley Brian M

director, officer: President and CEO • 2 txns

Bradsher Neal C

director, 10 percent owner: • 1 txns

Jayasuriya Anula

director • 1 txns

Mulroy Michael H.

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 1, 2026	Bradsher Neal C	director, 10 percent owner:	OPTION TO PURCHASE COMMON SHARES	A	125,000	$1.30	$162,500.00
Jul 1, 2026	Jayasuriya Anula	director	Stock Option (Right to Buy)	A	125,000	$1.30	$162,500.00
Jul 1, 2026	Mulroy Michael H.	director	Stock Option (Right to Buy)	A	125,000	$1.30	$162,500.00
Jul 1, 2026	ANDREWS DEBORAH J	director	Stock Option (Right to Buy)	A	125,000	$1.30	$162,500.00
Jul 1, 2026	Russell Angus C.	director	Stock Option (Right to Buy)	A	125,000	$1.30	$162,500.00
Jul 1, 2026	Amin Dipti	director	Stock Option (Right to Buy)	A	125,000	$1.30	$162,500.00
Mar 12, 2026	Culley Brian M	director, officer: President and CEO	Common Shares	A	15,000	$1.63	$24,375.00
Mar 5, 2026	Culley Brian M	director, officer: President and CEO	Employee Stock Option (Right to Buy)	A	3,250,000	$1.84	$5,980,000.00
Mar 5, 2026	Howe Jill Ann	officer: Chief Financial Officer	Employee Stock Option (Right to Buy)	A	1,050,000	$1.84	$1,932,000.00
Mar 5, 2026	Samuel George A. III	officer: General Counsel and Secretary	Employee Stock Option (Right to Buy)	A	900,000	$1.84	$1,656,000.00

Upstream

Factor Bioscience Inc.Thermo Fisher Scientific Inc.NYSE:TMO Corning IncorporatedNYSE:GLWMerck KGaA (MilliporeSigma)XETRA:MRKCryoport Inc.NASDAQ:CYRX Ernexa Therapeutics Inc. (f/k/a Eterna Therapeutics)NASDAQ:ERNA

Downstream

F. Hoffmann-La Roche AG / Genentech Inc. (Roche Group)SWX:ROWilliam Demant Invest 2 ApS (Demant A/S)CPH:DEMANTCancer Research UKImmunomic Therapeutics Inc.UC San Diego Health / Clinical Trial SitesCalifornia Institute for Regenerative Medicine (CIRM)

Proxies

Roche Holding AGSWX:RODemant A/SCPH:DEMANTThermo Fisher Scientific Inc.NYSE:TMOFactor Bioscience Inc.Cryoport Inc.NASDAQ:CYRX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Lineage Cell Therapeutics, Inc.

Insider Transactions of LCTX

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of LCTX

Upstream

Downstream

Proxies

Insider Transactions of LCTX

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of LCTX

Upstream

Downstream

Proxies